Evaluation of Coagulation in Multiple Sclerosis
NCT01711255 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 69
Last updated 2017-07-28
Summary
Recent research in multiple sclerosis (MS) have suggested that altered coagulation and vascular inflammation may play a role in pathophysiology of MS. Sonoclot is viscoelastic method of analyzing clot formation. This instrument will be used to compare coagulation in individuals with MS to healthy controls. A 24-hour dietary recall and food frequency questionnaire will help determine whether coagulation is modified by fish consumption.
Conditions
Sponsors & Collaborators
-
Bastyr University
lead OTHER
Principal Investigators
-
Laurie K Mischley, ND · Bastyr University - Clinical Research Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-10-31
- Primary Completion
- 2016-05-31
- Completion
- 2016-05-31
Countries
- United States
Study Locations
More Related Trials
-
Relationship Between the Nutritional Habits and Relapsing and Disability Rates in Patient With Multiple Sclerosis.
NCT04110171 ·Status: UNKNOWN
-
The MURDOCK Study Community Registry and Biorepository Multiple Sclerosis Cohort
NCT01723709 ·Status: COMPLETED
-
Analyze the Myelin-TRAP as Diagnostic Tool in Multiple Sclerosis
NCT01723631 ·Status: TERMINATED ·Phase: NA
-
Baseline Cortical Haemodynamics in MS
NCT02481882 ·Status: UNKNOWN ·Phase: NA
-
A Study to Assess the Effects of MK0812 on Disease Activity in Patients With Relapsing-Remitting Multiple Sclerosis as Measured by Magnetic Resonance Imaging (MRI)(0812-003)(COMPLETED)
NCT00239655 ·Status: TERMINATED ·Phase: PHASE2
-
Multiparametric Assessment to Investigate Prognostic Factors for Disease Evolution a nd Evolutionary Patterns of Cognitive Status in RRMS
NCT05510817 ·Status: RECRUITING ·Phase: NA
-
Serial Collection of Primary Progressive Multiple Sclerosis Participants in the MURDOCK Study
NCT01776060 ·Status: COMPLETED
-
A Cross-Sectional Study of MSDx Complex 1 as a Marker for Active Disease in Multiple Sclerosis
NCT01539395 ·Status: WITHDRAWN
-
Assessment of Patients With Multiple Sclerosis (MS)
NCT00001156 ·Status: COMPLETED
-
Fatigue in Multiple Sclerosis: Evaluated With 3 MRI and Transcranial Magnetic Stimulation
NCT00342381 ·Status: COMPLETED ·Phase: PHASE2
-
Complementary and Alternative Care in Multiple Sclerosis
NCT01703429 ·Status: RECRUITING
-
An Observational Biomarker Study in Multiple Sclerosis (MS) Patients
NCT05663853 ·Status: COMPLETED
-
Physiological Effects of N-Acetyl Cysteine in Patients With Multiple Sclerosis
NCT03032601 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Photobiomodulation Therapy in Persons With Multiple Sclerosis
NCT03691766 ·Status: COMPLETED ·Phase: NA
-
A Study of MK-2225 in Healthy Participants (MK-2225-003)
NCT06643390 ·Status: COMPLETED ·Phase: PHASE1
-
Neurofilament Light Chain ,Chitinase-3 Like-1 Proteins and Plasmacytoid Dendritic Cells in Multiple Sclerosis
NCT05451069 ·Status: UNKNOWN
-
Neuroprotection With N-acetyl Cysteine for Patients With Progressive Multiple Sclerosis
NCT05122559 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Immunologic Biomarker Profile of Cerebrospinal Fluid
NCT04202055 ·Status: COMPLETED
-
Venous Irregularities, Flow and Perfusion in MS Study
NCT01593904 ·Status: UNKNOWN
-
A Study to Evaluate the Safety, Tolerability, Kinetics, Biodistribution and Repeatability of 11C-BMS-986196 After Intravenous (IV) Administration in Healthy Participants and After Repeat IV Administration in Participants With Multiple Sclerosis
NCT05064436 ·Status: TERMINATED ·Phase: PHASE1
-
Evaluating Multiple Sclerosis Patients ShOWing A GEnomic Signature of Therapy Response
NCT03316404 ·Status: COMPLETED
-
Study to Evaluate the Safety, Tolerability, and Activity of CM-101 in Patients With Systemic Sclerosis
NCT06210945 ·Status: SUSPENDED ·Phase: PHASE2
-
Bayer/Cognitive Assessments With Multiple Sclerosis Subjects
NCT00888277 ·Status: COMPLETED
-
Investigating Mechanism of Action of DAC HYP in the Treatment of High-Inflammatory Multiple Sclerosis (MS)
NCT01143441 ·Status: COMPLETED ·Phase: PHASE1
-
VALIDATE: Factor VIII Trending for MS Relapse
NCT04082468 ·Status: WITHDRAWN